Navigation Links
Scavenger cells accomplices to viruses
Date:7/21/2011

This release is available in German.

Mucosal epithelia do not have any receptors on the outer membrane for the absorption of viruses like hepatitis C, herpes, the adenovirus or polio, and are thus well-protected against pathogenic germs. However, certain viruses, such as the human immunodeficiency virus HIV, still manage to enter the body via the mucous membrane. Just how this infiltration occurs on a molecular level has been a mystery. Three hypotheses were discussed: firstly, that it's caused by mechanical damage to the mucous membrane; secondly, the presence of previously unknown receptors on the mucous membrane cells; and, thirdly, that the viruses are smuggled in via a kind of Trojan horse. Now, for the first time, cell biologists from the University of Zurich have succeeded in identifying the infection mechanism for adenoviruses.

In the recently published online magazine Nature Communications, Verena Ltschg and cell biologists from the Institute of Molecular Biology headed by Urs Greber reveal how type-5 adenoviruses in the lung epithelia utilize an immune response triggered by the infection for the progression of the infection: Adenoviruses use scavenger cells and their subsequent production of antiviral cytokines as a door-opener for the infection of the lung epithelial cells.

Exposure of shielded receptors

Antiviral cytokines play a key role in immunological reactions and trigger inflammatory responses, for instance. They induce the epithelial cells to expose certain receptors that are shielded under normal conditions and thus activate immune cells in defense. For healthy people, an infection of the lung with type-5 adenoviruses is harmless as they merely cause a cold. Under very stressful situations or in the case of chronic respiratory diseases, however, adenoviruses can cause severe, acute infections that can sometimes be fatal.

The recently identified infection mechanism can serve as a model for how the pathogens penetrate the mucosal epithelial cells and enter the body. However, it is also crucial from a therapeutic point of view. Type-5 adenoviruses are already used very often as transport vehicles in cancer-gene therapy today. Knowing the transport route will help develop both this gene therapy and specifically acting cancer treatment further.


'/>"/>

Contact: Prof. Urs Greber
urs.greber@imls.uzh.ch
41-446-354-841
University of Zurich
Source:Eurekalert

Related biology news :

1. Increase in Cambodias vultures gives hope to imperiled scavengers
2. When the dinner bell rings for seafloor scavengers, larger animals get first dibs
3. Engineering excitable cells for studies of bioelectricity and cell therapy
4. USC research: Cancer cells and stem cells share same origin
5. Cancer stem cells recruit normal stem cells to fuel ovarian cancer, U-M study finds
6. Stem cells restore cognitive abilities impaired by brain cancer treatment
7. Deeper insight in the activity of cortical cells
8. Sertoli cells show promise for therapeutics
9. Scientists discover how best to excite brain cells
10. Unnatural chemical allows Salk researchers to watch protein action in brain cells
11. Scientists devise way to sort brain cells for potential transplants
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/12/2017)... 12, 2017  Trovagene, Inc. (NASDAQ: TROV ... today announced that it has signed agreements with seven ... the Middle East for commercialization ... the first wave of international distribution agreements for Trovagene,s ... samples. The initial partners will introduce Trovagene,s ...
(Date:1/12/2017)... PORTLAND, Oregon and PUNE, India , January 12, 2017 ... Technology Market: Opportunities and Forecasts, 2015 - 2022," projects that the global biometric technology ... CAGR of 19.4% from 2016 to 2022. Continue Reading ... ... ...
(Date:1/11/2017)... NEW BRUNSWICK, N.J. , Jan. 11, 2017  Michael Johnson, ... from Foundation Venture Capital Group, Inc., has been named to the ... Johnson, 27,  was one of 600 people in 20 fields ... only four percent of the 15,000 applicants were selected. ... He is currently a PhD ...
Breaking Biology News(10 mins):
(Date:1/17/2017)... ... January 17, 2017 , ... LGC ... to its VALIDATE® SP2 calibration verification / linearity test kit. VALIDATE® SP2 evaluates ... Each VALIDATE® SP2 kit is prepared using the CLSI recommended “equal delta” method ...
(Date:1/17/2017)... 17, 2017  Zimmer Biomet Holdings, Inc. (NYSE and ... 2016 sales and earnings conference call will be broadcast ... at 8 a.m. Eastern Time.  A news release detailing ... at 7:30 a.m. Eastern Time the morning of the ... be accessed via Zimmer Biomet,s Investor Relations website at ...
(Date:1/17/2017)... MANHASSET, N.Y. , Jan. 17, 2017 /PRNewswire-USNewswire/ ... to speed the advance of precision cancer research. ... State,s largest health care provider, Northwell ... each year. Indivumed, GmbH is a ... individualize anti-cancer medical therapies. Together they will greatly ...
(Date:1/17/2017)... ... January 17, 2017 , ... Diagenode, a ... announced a collaboration with the Heidelberg University Hospital and the German Cancer Research ... following the company’s successful launch of its CATS (Capture and Amplification by ...
Breaking Biology Technology: